Calculation of Filing Fee Tables
Form S-3
(Form Type)
Iradimed Corporation
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered(1) | Proposed Maximum Offering Price Per Unit(1) | Maximum Aggregate Offering Price(1) | Fee Rate | Amount of Registration Fee |
Equity | Common Stock, $0.0001 par value per share | Rule 457(o) | — | — | $75,000,000 | 0.00014760 | $11,070 |
— | — | — | — | | — | | — |
— | — | — | — | | — | | |
Total Offering Amounts | | $75,000,000 | | $11,070 |
Total Fee Offsets(2) | | | | $5,192 |
Net Fees Due(2) | | | | $5,878 |
(1) | An indeterminate aggregate number of shares of common stock of Iradimed Corporation (the “Registrant”) is being registered as may be issued from time to time at currently indeterminable prices with an aggregate maximum offering price not to exceed $75,000,000. |
(2) | Pursuant to Rule 457(p) under the Securities Act of 1933, as amended (the “Securities Act”), the Registrant is offsetting the registration fee due under this Registration Statement on Form S-3 (this “Registration Statement”) to which this Exhibit 107 is a part by $5,192, which represents the portion of the registration fee previously paid by the Registrant with respect to $40,000,000 of unsold securities previously registered on the Registration Statement on Form S-3 (File No. 333-248192), initially filed with the Securities and Exchange Commission on August 20, 2020. Accordingly, the Registrant is only submitting $5,878 filing fees in connection with this Registration Statement. |
Table 2: Fee Offset Claims and Sources
| Registrant or Filer Name
| | Form or Filing Type | | File Number | | Initial Filing Date | | Filing Date | | Fee Offset Claimed | | Security Type Associated with Fee Offset Claimed | | Security Title Associated with Fee Offset Claimed | | Unsold Securities Associated with Fee Offset Claimed | | Unsold Aggregate Offering Amount Associated with Fee Offset Claimed | | Fee Paid with Fee Offset Source | |
| | | | | | | | | | | | | Rule 457(p)
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Fee Offset Claims | Iradimed Corporation | | | | S-3(3) | | | | 333-248192 | | August 20, 2020 | | | | | $ | 5,192 | | | | (4 | ) | | | (4 | ) | | | (4 | ) | | $ | 40,000,000 | | | |
Fee Offset Sources | Iradimed Corporation | | | | S-3(3) | | | | 333-248192 | | | | August 20, 2020 | | | | | | | | | | | | | | | | | | | | | | | $ | 5,192 | |
(3) | The Registrant has either withdrawn each the registration statement or has terminated or completed any offering that included the unsold securities under the prior registration statement. |
(4) | The securities offered thereunder were up to $40,000,000 aggregate initial offering price of such indeterminate number of shares of common stock. |